Effects of temperature on stability of blood homocysteine in collection tubes containing 3-deazaadenosine

Clinical Chemistry

Volumn 48, Issue 11, 2002, Pages 2017-2022

  Hill, Diane M ^a   Johnson, Lisa J ^a   Burns, Paul J ^a   Neale, Angela M ^a   Harmening, Denise M ^a   Kenney, Andrew C ^a  

^a Drew Scientific Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 DEAZAADENOSINE; EDETIC ACID; HOMOCYSTEINE;

ACCURACY; ARTICLE; BLOOD SAMPLING; BLOOD STORAGE; ENVIRONMENTAL TEMPERATURE; FREEZING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PLASMA; TEMPERATURE SENSITIVITY;

EID: 0036839777     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/48.11.2017     Document Type: Article

References (39)

1. Finkelstein JD. Methionine metabolism in mammals [Review]. J Nutr Biochem 1990;1:228-37.
2. McCully KS. Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969;56:111-28.
3. McCully KS, Ragsdale BD. Production of arteriosclerosis by homocysteinemia. Am J Pathol 1970;61:1-11.
4. Vollset SE, Refsum H, Tverdal A, Nygard O, Nordrehaug JE, Tell GS, et al. Plasma total homocysteine and cardiovascular and noncardiovascular mortality: The Hordaland Homocysteine Study. Am J Clin Nutr 2001;74:130-6.
5. van der Put NM, van Straaten HW, Trijbels FJ, Blom HJ. Folate, homocysteine and neural tube defects: An overview. Exp Biol Med (Maywood) 2001;226:243-70.
6. McCaddon A, Hudson P, Davies G, Hughes A, Williams JH, Wilkinson C. Homocysteine and cognitive decline in healthy elderly. Dement Geriatr Cogn Disord 2001;12:309-13.
7. McCaddon A, Davies G, Hudson P, Tandy S, Cattell H. Total serum homocysteine in senile dementia of Alzheimer type. Int J Geriatr Psychiatry 1998;13:235-9.
8. Dudman NP. An alternative view of homocysteine. Lancet 1999;354:2072-4.
9. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes [Review]. JAMA 1995;274:1049-57.
10. Homocysteine Lowering Trialists' Collaboration. Lowering blood homocysteine with folic acid based supplements: Meta-analysis of randomised trials. BMJ 1998;316:894-8.
11. Malinow MR, Duell PB, Hess DL, Anderson PH, Kruger WD, Phillipson BE, et al. Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease. N Engl J Med 1998;338:1009-15.
12. Wald DS, Bishop L, Wald NJ, Law M, Hennessy E, Weir D, et al. Randomized trial of folic acid supplementation and serum homocysteine levels. Arch Intern Med 2001;161:695-700.
13. Bostom AG, Garber C. Endpoints for homocysteine-lowering trials. Lancet 2000;355:511-2.
14. Miller JW. Does lowering plasma homocysteine reduce vascular disease risk? Nutr Rev 2001;59:242-4.
15. 6 on progression of subclinical atherosclerosis: A randomised, placebo-controlled trial. Lancet 2000;355:517-22.
16. Andersson A, Isaksson A, Hultberg B. Homocysteine export from erythrocytes and its implication for plasma sampling. Clin Chem 1992;38:1311-5.
17. Vester B, Rasmussen K. High performance liquid chromatography method for rapid and accurate determination of homocysteine in plasma and serum. Eur J Clin Chem Clin Biochem 1991;29:549-54.
18. Ducros V, Candito M, Causse E, Couderc R, Demuth K, Diop ME, et al. [Plasma homocysteine measurement: A study of pre-analytical variation factors for conditions for total plasma homocysteine concentration]. Ann Biol Clin (Paris) 2001;59:33-9.
19. Fiskerstrand T, Refsum H, Kvalheim G, Ueland PM. Homocysteine and other thiols in plasma and urine: Automated determination and sample stability. Clin Chem 1993;39:263-71.
20. Kittner SJ, Malinow MR, Seipp MJ, Upson B, Hebel JR. Stability of blood homocyst(e)ine under epidemiological field conditions [published erratum appears in J Clin Lab Anal 1995:9:342]. J Clin Lab Anal 1995:9:75-6.
21. Korzun WJ, Ho QV. Stability of plasma total homocysteine concentrations in EDTA-whole blood kept on ice. Clin Lab Sci 2000;13:196-8.
22. O'Broin SD, Kelleher BP, McPartlin J, O'Gorman P, Browne M, White B, et al. Optimization of routine plasma homocysteine monitoring. Blood Coagul Fibrinolysis 2000;11:367-9.
23. Salazar JF, Herbeth B, Siest G, Leroy P. Stability of blood homocysteine and other thiols: EDTA or acidic citrate? [Technical Brief]. Clin Chem 1999;45:2016-9.
24. Willems HP, Bos GM, Gerrits WB, den Heijer M, Vloet S, Blom HJ. Acidic citrate stabilizes blood samples for assay of total homocysteine [Technical Brief]. Clin Chem 1998;44:342-5.
25. Caliskan S, Kuralay F, Onvural B. Effect of anticoagulants on plasma homocysteine determination. Clin Chim Acta 2001;309:53-6.
26. Moller J, Rasmussen K. Homocysteine in plasma: Stabilization of blood samples with fluoride. Clin Chem 1995;41:758-9.
27. Brandl R, Probst R, Muller B, Powarzynski S, Maurer PC, Neumeier D. Evaluation of the measurement of lysate homocysteine in patients with symptomatic arterial disease and in healthy volunteers [Technical Brief]. Clin Chem 1999;45:699-702.
28. Oberrauch W, Gibson D, Fink HS, Lorenz B, Gotzrath M, Brutsch G, et al. Capillary blood, an alternative source for easy homocysteine testing. Clin Lab 1999;45:627-30.
29. Probst R, Brandl R, Blumke M, Neumeier D. Stabilization of homocysteine concentration in whole blood [Technical Brief]. Clin Chem 1998;44:1567-9.
30. Hughes MP, Carlson TH, McLaughlin MK, Bankson DD. Addition of sodium fluoride to whole blood does not stabilize plasma homocysteine but produces dilution effects on plasma constituents and hematocrit [Technical Brief]. Clin Chem 1998;44:2204-6.
31. al Khafaji F, Bowron A, Day AP, Scott J, Stansbie D. Stabilization of blood homocysteine by 3-deazaadenosine. Ann Clin Biochem 1998;35:780-2.
32. Hill D, Kenney A. Effect of temperature on the stabilization of blood homocysteine concentration by 3-deazaadenosine [Abstract]. Clin Chem 2000;46:A37.
33. World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA 2000;284:3043-5.
34. Zhang M, Gunter EW, Pfeiffer CM. Evaluation of the Drew Scientific DS30 homocysteine assay in comparison with the Centers for Disease Control and prevention reference HPLC method [Technical Brief]. Clin Chem 2001;47:966-7.
35. Tukey JW. The problem of multiple comparisons. In: Braun HI, ed. The Collected Works of John W. Tukey. New York: Chapman & Hall, 1994:1-300.
36. Kenney A, Hill D, Hadley R. A plasma homocysteine reference range study conducted using the Drew Scientific DS30 HCY assay [Abstract]. Clin Chem Lab Med 1999;37:S341.
37. Duarte NL, Wang XL, Wilcken DE. Effects of anticoagulant and time of plasma separation on measurement of homocysteine [Technical Brief]. Clin Chem 2002;48:665-8.
38. Dawling S. Stabilizing blood with 3-deazaadenosine interferes in the Abbott FPIA assay for plasma homocyst(e)ine. Ann Clin Biochem 1999;36:669-70.
39. Woltersdorf WW, Bowron A, Day AP, Scott J, Stansbie D. Abbott IMx homocysteine assay: Significant interference by 3-deazaadenosine [Letter]. Ann Clin Biochem 1999;36:533.